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Dengue, the most rapidly spreading 
vector-transmitted virus, yields a sig-
nificant public health, economic, and so-
cial burden in Asia and Latin America. 
The importance of dengue as a public 
health threat is demonstrated in the 
exponentially growing incidence within 
endemic countries (1) together with a re-
cent spreading to previously “transmis-
sion-free” areas, such as the United 
States (2), Croatia and France (3), and 
Portugal (4), following the geographic 
distribution of its vectors. Cases are also 
increasingly reported from the African 
continent (5). This remarkable global 
range expansion, reaching a global bur-
den of 390 million infections per year, of 
which 96 million are symptomatic (6) 
and about 24 000 are fatal (7), is closely 
tied to global trends in population 
growth, unplanned urbanization, wide-
spread travel, and globalization (8). 
Based on the disability-adjusted life 
years (DALYs) metric, dengue is respon-
sible for an average annual loss of 658 
DALYs per million population in Latin 
America and the Caribbean, the same 
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order of magnitude as tuberculosis in 
this region (9, 10). The costs of treating 
clinical and severe (hospitalized) cases, 
the economic and social costs of loss of 
productive time, and the costs for con-
trolling epidemics are exploding (9, 11).
The main mosquito vectors Aedes 
aegypti and Ae. albopictus can be found in 
the tropical and subtropical region, pre-
dominantly in urban environments, al-
though recent empiric evidence has 
documented their expansion into rural 
areas (12–14). The four distinct but 
closely related dengue virus serotypes 
cause a wide range of disease manifesta-
tions. Dengue infection frequently re-
mains asymptomatic but can cause 
classical dengue fever (an acute systemic 
disease characterized by fever, headache, 
and arthralgia/myalgia lasting for 5–7 
days) or appear as a potentially lethal, 
severe disease with plasma leakage, with 
or without haemorrhagic signs. Sero-
type-specific immunity is lifelong but 
progression to more serious disease is 
frequently albeit not exclusively associ-
ated with secondary infection by heterol-
ogous dengue serotypes (15). Recent 
experimental feeding trials have docu-
mented the ability of individuals with 
asymptomatic infections to infect Ae. ae-
gypti mosquitoes (16), leading to a new 
public health challenge in the surveil-
lance and control of urban dengue.
Limitations of current dengue 
control strategies
The control of dengue is mainly based 
on the control of its vectors at different 
life stages, as prevention by immuniza-
tion is not yet programmatically avail-
able (but foreseeable in the future). The 
Phase III trials in Asia and Latin Amer-
ica of a leading life-attenuated candidate 
vaccine (yellow fever vaccine backbone) 
yielded efficacy rates for symptomatic 
dengue of 44.6% and 65.6% in people < 9 
years old and ≥ 9 years old respectively 
(17). Unlike the vaccine for yellow fever, 
the development of a dengue vaccine is 
challenged by the need for a balanced 
immune response in order to address 
the theoretical risk of immune enhance-
ment (18). Other vaccines are in the 
pipeline, such as the life-attenuated can-
didate that uses a DENV4 backbone, 
which has shown promising results in a 
Phase II study (18, 19). There is a grow-
ing consensus that eliminating dengue 
as a public health burden can only be 
achieved by integrating effective vector 
control with selective vaccination (once 
the vaccine is available), given the com-
plementarity of the two approaches, and 
the expectation of a synergistic effect 
(20). The recent spread of other arbovi-
ruses transmitted by Aedes, such as 
chikungunya and Zika (21, 22), for 
which no vaccine is available, under-
scores the importance of controlling this 
vector within the umbrella of an inte-
grated disease management plan.
Common approaches to control Aedes 
(i.e., those used by the disease control 
programs of dengue-endemic countries 
(23)) are directed at the insect’s larval 
stages and include the application of 
chemical larvicides or biological tools in 
water storage containers and mechanical 
destruction of non-useful containers filled 
with rainwater (environmental manage-
ment), accompanied, or not, by commu-
nity participation and a communication 
for behavioral impact (COMBI) strategy. 
These approaches can also target the 
adult mosquito, using methods such as 
outdoor and/or (less frequently) indoor 
insecticide space-spraying or fogging. In-
door residual spraying, when performed 
properly, has shown significant impacts 
in preventing dengue disease when ap-
plied in a top-down, regimented way 
(24). Some new tools, such as insecti-
cide-treated materials, and lethal ovitraps 
(a device partly submerged in a cup of 
water that mimics container-breeding 
mosquitos’ breeding habitats) have re-
cently become available (25–28). Other 
strategies still under evaluation are de-
signed to reduce the Aedes population 
through the release of genetically modi-
fied mosquitoes (the Release of Insects 
with Dominant Lethality (RIDL) ap-
proach) or Wolbachia-infected mosquitoes 
(20). As an alternative option for dengue 
control, efforts can be made to decrease 
human–vector contact through the appli-
cation of repellents at the individual level 
and screening doors/windows at the 
household level (26).
Most of the vector control measures 
have shown some degree of effective-
ness (29) when intensive and standard-
ized application processes are used, 
high coverage is reached, and sustained 
uptake is secured (7). However, under 
routine conditions, none of these mea-
sures has shown potential to halt trans-
mission, due to, at least in part, the 
above-mentioned implementation chal-
lenges, as well as the increasing levels of 
resistance of local vectors to both larvi-
cides and adulticides (30–32).
Current dengue control strategies in 
dengue-endemic countries mainly com-
prise dispersed and irregular control ac-
tions carried out in response to detected 
clinical cases, and/or massive insecticide 
application designed to mitigate out-
breaks. These “response measures” are 
usually carried out several days or weeks 
after infection occurred, and are directed 
toward case houses, which may not be 
the major site of infection (33). The spray-
ing of adulticide is often implemented 
after the peak of the epidemic (34). In con-
trast, a few countries conduct proactive 
vector control operations on a regular ba-
sis, and at nationwide scale, but the high 
costs (up to US$ 24 per inhabitant per 
year (35)) make them difficult to sustain.
The way forward
In order to design a more rational and 
appropriate approach (i.e., suitable for 
countries where dengue is endemic or 
epidemic), current control strategies 
need to be re-thought, taking into con-
sideration, as a starting point, the vari-
ous demographic, environmental, and 
social conditions that drive dengue 
transmission dynamics. Even if it does 
not immediately address the distal deter-
minants of the problem, the new para-
digm in dengue control should not 
be designed with the assumption 
that transmission intensity is the same 
everywhere. It should consider the 
spatially heterogeneous character of 
dengue transmission risk at the city level 
and hence stratify geographic areas. 
Whenever possible the different strata 
should be defined and control efforts dif-
ferentiated by the risk conditions that 
make them more or less exposed/vul-
nerable to dengue transmission. The 
 research team revisited evidence on 
dengue epidemiology to support this 
new paradigm in dengue control, keep-
ing in mind the need for a strategy that is 
more effective and efficient.
In the sections below, the authors 1) 
outline this targeted, proactive inter-
vention strategy, within the context of 
dengue epidemiology, the dynamics of 
its transmission, and current Aedes con-
trol strategies, and 2) provide support 
from published literature for the need to 
empirically test its impact on dengue 
transmission as well as on the size of 
disease outbreaks.
Rev Panam Salud Publica 41, 2017 3
Vanlerberghe et al. • Changing paradigms in Aedes control: spatial heterogeneity of dengue transmission Current topic
Identifying areas with high risk for 
dengue transmission. Transmission of 
infectious diseases in general and vec-
tor-borne diseases specifically is known 
to be highly heterogeneous in terms of 
space and time (36–38). Mathematical 
models indicate that infectious disease 
interventions that are targeted spatially 
(and/or temporally) can be more effec-
tive than those applied evenly across dif-
ferent locations and time periods (39). 
Transmission of dengue has also shown 
spatial and temporal heterogeneity. Spa-
tial areas of elevated risk for dengue were 
identified at the sub-city level in Peru 
and at the district level in Vietnam (40, 
41). The stability of spatial patterns of 
dengue incidence was highlighted in re-
search carried out by Barrera et al. (42) in 
a hyperendemic city in Venezuela, where 
70% of reported cases over a five-year pe-
riod occurred in 35% of all neighbor-
hoods (where 55% of the city inhabitants 
lived). In Cairns, a non-endemic city in 
Australia, an analysis of the spatio-tem-
poral dimension of dengue virus trans-
mission demonstrated that 18 space–time 
clusters involved 65% of cases, and most 
dengue introductions leading to epi-
demic propagation occurred within the 
coastal (and much older) neighborhoods 
of the city (24).
Based on the malaria hotspot defini-
tion provided by Bousema (43), areas 
with a high risk for dengue transmission 
could be defined as geographic sites 
where transmission intensity exceeds 
the average level. But unlike malaria, av-
erage transmission for dengue must be 
framed within temporal scales because it 
is dependent on the amount of time that 
has elapsed since the dengue or a spe-
cific serotype was introduced to the area, 
the level of immunity to a specific sero-
type within the population, and the 
transmission intensity within an epi-
demic/endemic period. Various ap-
proaches can be used to assign different 
levels of risk to specific geographic ar-
eas, such as neighborhoods. Two of those 
approaches are described below. The 
first approach is based on measures of 
disease incidence; the second approach 
is based on measures of vulnerability.
One advantage of the approach based 
on disease incidence is that data on 
dengue cases at the population level are 
routinely available. However, the inci-
dence measure approach has several 
drawbacks, such as only capturing data 
from people who have visited public 
health services and for whom dengue 
was reported as the main diagnosis (44), 
and the variability of symptom presenta-
tion, which is partly dependent on previ-
ous dengue exposure. In addition, these 
types of data are associated with the resi-
dential address of each case, rather than 
the actual point of transmission, which 
limits estimations of true location-spe-
cific incidence, given that transmission 
could have occurred outside the neigh-
borhood/city where individuals live 
(45). In addition, a significant proportion 
of dengue infections are asymptomatic, 
even though they can still play an impor-
tant role in maintaining disease trans-
mission (16, 46). A better measure of past 
transmission would be dengue serotype–
specific seroprevalence, which includes 
asymptomatic infections. Unfortunately, 
such data are rarely available at the pop-
ulation level due to the high cost of the 
diagnostic procedures (47). However, in-
cidence and/or seroprevalence informa-
tion can be modeled afterward, looking 
at space–time correlations and taking 
into account possible covariates.
The second approach, based on mea-
sures of vulnerability, is designed to cap-
ture multiple dimensions of risk for 
dengue transmission, beyond the limited 
predictive ability for actual transmission of 
one determinant used in isolation. There-
fore, models based on this approach incor-
porate variables characterizing dengue 
transmission risk: entomologic (48), epi-
demiologic (49), demographic (50), behav-
ioral (33), and environmental (51, 52) 
factors. This multifactorial approach is in 
line with the Mesoamerican plan for inte-
grated dengue prevention and control 
(53). In a multidisciplinary meeting with 
dengue experts from academia and na-
tional control program managers (Havana, 
2014), specific factors within these deter-
minant groups were identified by munici-
pality or city (the level at which control 
programs are organized). Epidemiologic 
risk per neighborhood can be character-
ized based on several indicators: cumula-
tive incidence of dengue cases over a 5–10 
year period, the neighborhoods where the 
first cases usually appear, the persistence 
of case incidence in/between epidemics, 
and the serotype(s) that are circulating. 
The entomologic risk per neighborhood 
can be explained by two main indicators: 
the persistence of high indices over time, 
and cumulative infestation levels (over a 
period of 2–5 years). These indicators will 
need to be adapted for the local context of 
each country, as available entomologic in-
formation differs across countries in terms 
of the methods used, the frequency, and 
the geographic coverage of surveys. As de-
tailed information on entomologic infesta-
tion levels is often lacking or incomplete, 
the model should also include environ-
mental factors that enhance the probability 
of vector presence. Environmental and be-
havioral characteristics could include local 
risk behaviors or risk spots for Aedes in-
festation (e.g., cemeteries, tire storage ar-
eas). For demographic factors, it was 
found that, along with population density 
(or, if more appropriate, urbanization char-
acteristics from satellite imagery), it was 
important to take into account intensive 
human movement (54, 55). Factors such as 
temperature, rainfall, and altitude were 
not retained, as they hardly vary at the 
municipal or city level. However, in cases 
where they are deemed important, they 
could be added to the list of variables.
Criteria that must be defined and ques-
tions that must be answered before 
adapting the control paradigm to a tar-
geted intervention. Before designing an 
intervention strategy, based on the iden-
tification of high-risk areas, certain crite-
ria must be defined and certain research 
questions answered. One major criterion 
to define is the geographic scale at which 
the disease transmission areas need to be 
defined. To date, appraisal of heterogene-
ity has mainly been used operationally to 
identify vast subnational geographic en-
tities (e.g., provinces) to direct dengue 
control actions (56). However, some re-
searchers have observed that heterogene-
ity of transmission is better exploited on 
a smaller scale, because vector infestation 
levels and risk for dengue transmission 
can differ markedly from one neighbor-
hood to another within the same city (57). 
For example, in Peru, it has been shown 
that neighborhoods (aggregated spatial 
units) have a higher level of stability as 
transmission-risk units than individual 
households (58). Based on these findings, 
and on the operationalization of routine 
programs, neighborhoods could be a bet-
ter target for focusing control efforts than 
the household or the entire city.
A second criterion that needs to be de-
fined/verified is the stability/persistence 
of dengue transmission risk within the se-
lected geographic units. The evidence on 
geographic consistency of clinical dengue 
incidence and Aedes infestation is scarce, 
uses different geographic scales, and is 
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quito pools coinfected with both dengue 
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Expected breakthrough if successful
If successful, the methodologies 
used and the results of the identification 
of areas at high risk for dengue 
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transmission could be useful for 1) the 
organization of health services for case 
management (i.e., preparation for 
high-transmission season); 2) the selec-
tion of sites for sentinel surveillance (a 
system proposed by PAHO11); and 3) the 
development of a strategy for scaling up 
control efforts and/or the deployment 
of a future dengue vaccine. If proven ef-
fective, the targeting strategy could 
also benefit efforts to control the re-
cently spreading viruses, chikungunya 
and Zika.
Conclusions
An alternative dengue control strategy 
was identified based on the spatial het-
erogeneity characteristic of disease trans-
mission. Implementation studies are 
under way and will provide evidence on 
its effectiveness and cost-effectiveness.
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Román-Pérez S, Ríos-Salgado VH, et al. 
Nation-wide, web-based, geographic in-
formation system for the integrated sur-
veillance and control of dengue fever in 
Mexico. PLoS One. 2013;8(8):e70231.
 57. Sanchez L, Vanlerberghe V, Alfonso L, 
Marquetti Mdel C, Guzman MG, Bisset J, 
et al. Aedes aegypti larval indices and risk 
for dengue epidemics. Emerg Infect Dis. 
2006;12(5):800–6.
 58. LaCon G, Morrison AC, Astete H, 
Stoddard ST, Paz-Soldan VA, Elder JP, 
et al. Shifting patterns of Aedes aegypti 
fine scale spatial clustering in Iquitos, 
Peru. PLoS Negl Trop Dis. 2014;8(8):e3038.
 59. Barrera R. Spatial stability of adult Aedes 
aegypti populations. Am J Trop Med Hyg. 
2011;85(6):1087–92.
 60. Dom NC, Ahmad AH, Latif ZA, Ismail R. 
Measurement of dengue epidemic spread-
ing pattern using density analysis method: 
retrospective spatial statistical study of 
dengue in Subang Jaya, Malaysia, 2006–
2010. Trans R Soc Trop Med Hyg. 2013;107 
(11):715–22.
 61. Bhoomiboonchoo P, Gibbons RV, Huang 
A, Yoon IK, Buddhari D, Nisalak A, et al. 
The spatial dynamics of dengue virus in 
Kamphaeng Phet, Thailand. PLoS Negl 
Trop Dis. 2014;8(9):e3138.
 62. Dzul-Manzanilla F, Martinez N, Cruz-
Nolasco M, Gutierrez-Castro C, Lopez-
Damian L, Ibarra-Lopez J, et al. Evidence 
of vertical transmission and co-circulation 
of chikungunya and dengue viruses in 
field populations of Aedes aegypti (L.) 
from Guerrero, Mexico. Trans R Soc Trop 
Med Hyg. 2016;110(2):141–4. doi: 10.1093/
trstmh/trv106. Epub 2015 Dec 28.
Manuscript submitted 17 December 2015. Revised 
version accepted for publication on 18 May 2016.
RESUMEN Las estrategias actuales de control de vectores del dengue, centradas en la ejecución 
reactiva de intervenciones con insecticidas en respuesta a la aparición de cuadros clíni-
cos evidentes de la enfermedad, suelen ser ineficientes, de duración limitada e insos-
tenibles en el contexto epidemiológico mundial, caracterizado por la recrudescencia 
de las epidemias virales. Como resultado de una serie de reuniones y deliberaciones 
entre expertos, está en proceso un cambio de paradigma y ha surgido una nueva 
estrategia, que consiste en estratificar el riesgo de cada ciudad para concentrar y man-
tener los esfuerzos proactivos donde hay un alto riesgo de transmisión. En este 
artículo, los autores 1) describen esta estrategia de intervención específica y proactiva 
dentro del contexto de las características epidemiológicas del dengue, la dinámica de 
su transmisión y las estrategias actuales de control de Aedes y 2) fundamentan con 
fuentes bibliográficas la necesidad de demostrar empíricamente las repercusiones de 
esta estrategia sobre la transmisión del dengue y el tamaño de los brotes. Dado que los 
virus del chikunguña y el Zika siguen ampliando su alcance, uno de los objetivos pri-
mordiales de la planificación de la atención integrada de estas enfermedades estará 
determinado por la necesidad de adoptar un enfoque científico y proactivo del control 
urbano de los mosquitos del género Aedes. 
Cambio de paradigma en el 
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